PipelinePress ReleaseServices Acellera and Chemotargets to Collaborate -Enhancing AI and Physics Based Drug Discovery A formal collaboration to advance a common internal pipeline of drug development projects Barcelona, 16…Montserrat CasesMarch 16, 2022
Press ReleaseProducts CloudScientific and Chemotargets announce a new partnership to advance translational safety analysis in China CloudScientific as the local distributor in China of Chemotargets’ CLARITY and CLARITY PV technology platforms Shanghai,…Montserrat CasesJanuary 17, 2022
PipelinePress ReleaseScienceServices Chemotargets and the CRG ally to accelerate the development of new treatments Drug discovery biotech firm Chemotargets and the Centre for Genomic Regulation (CRG) have signed a…Montserrat CasesOctober 26, 2021
DisseminationPress ReleaseProducts Chemotargets launches CLARITY PV, a new web-based platform for translational safety and pharmacovigilance This week Chemotargets announces the launch of CLARITY PV, a new product for translational safety…Montserrat CasesJuly 5, 2021
Press ReleaseProductsScience Chemotargets has been awarded the Innovative SME Seal from the Spanish Ministry of Science and Innovation The Innovative SME Seal, valid for three years, recognizes the high level of innovation in…Montserrat CasesJune 3, 2021
PipelinePress ReleaseScienceServices Chemotargets Announces First AI-Designed Drug for Huntington’s Disease to Enter Clinical Trials In less than 12 months, the collaboration between Chemotargets and Galyan Bio yields a scaffold…Montserrat CasesApril 22, 2021
Press Release Dr. Scott Boyer joins Chemotargets as new CEO With the new incorporation, the company consolidates its transition from a software business to an…Montserrat CasesOctober 14, 2020
Press Release Chemotargets enters a new phase of growth – from a software company to a drug discovery biotech This public-private partnership will establish a framework for collaboration that promotes the creation of synergies…Montserrat CasesMay 25, 2020
Press ReleaseProducts The FDA licenses Chemotargets CLARITY platform The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) has licensed…Montserrat CasesMay 6, 2020
Press Release Chemotargets opens an investment round to enter a new phase of growth GENESIS Biomed and CREA Inversión will advise in the funding, which will allow the company…Montserrat CasesApril 16, 2020